Search

Your search keyword '"Jutel, Marek"' showing total 919 results

Search Constraints

Start Over You searched for: Author "Jutel, Marek" Remove constraint Author: "Jutel, Marek"
919 results on '"Jutel, Marek"'

Search Results

1. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

2. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

4. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

5. Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19

6. Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19

9. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

10. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

14. EAACI guidelines on environmental science for allergy and asthma: The impact of short‐term exposure to outdoor air pollutants on asthma‐related outcomes and recommendations for mitigation measures

16. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

17. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

18. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

19. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

20. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

21. Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper.

22. Indoor and outdoor pollutants—No safe amount of air to breathe in.

23. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

24. The impact of indoor pollution on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma

25. The impact of outdoor pollution and extreme temperatures on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma

28. Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper

30. Harnessing mass spectrometric methods for exquisite allergen product characterization.

31. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

32. Working with companies that manufacture breastmilk substitutes: An EAACI position paper.

33. Hot topics in allergen immunotherapy, 2023: Current status and future perspective.

34. Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper.

35. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

37. EAACI guidelines on the diagnosis of IgE‐mediated food allergy

38. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

39. Mentoring as the cornerstone of continued education in Allergy and Clinical Immunology: 10th anniversary of the EAACI mentorship program

40. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”

41. Four years into the COVID‐19 pandemic: Timely published articles for patient care and EAACI's leadership role.

42. ARIA guideline 2019: treatment of allergic rhinitis in the German health system

44. Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper

45. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

47. Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients

48. Mentoring as the cornerstone of continued education in Allergy and Clinical Immunology: 10th anniversary of the EAACI mentorship program.

49. List of Contributors

Catalog

Books, media, physical & digital resources